ANDA 201961, held by Lannett Co Inc. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 201961 (Phentermine Hydrochloride), held by Lannett Co Inc, was first approved by FDA on Jul 20, 2011, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 20, 2011 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride37.5MG · capsule;oral | Phentermine Hydrochloride | Discontinued |
| May 31, 2017 | Supplement 7Labeling · Standard review | Approved | None posted |
| Dec 5, 2012 | Supplement 3Labeling · Standard review | Approved | None posted |
| Apr 20, 2012 | Supplement 2Labeling | Approved | None posted |
| Feb 14, 2012 | Supplement 1Manufacturing | Approved | None posted |
| Jul 20, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters